Saturday 19 May 2012

Public Awareness

Novartis

Recall:FDA warns about painkiller mix-up in Excedrin, Bufferin

January 9, 2012 | No comments

The Associated Press reported a warning from the FDA about a potential mix-up between powerful prescription pain drugs and common …

Read more »
lapband

FDA issues Warning Letters for Misleading Advertising of Lap-Band

December 13, 2011 | No comments

The FDA issued warning letters for misleading Lap-Band advertising which the Agency states lacks information on the risks of gastric …

Read more »
MP900308900

Personal Health Information (PHI) in Corrective and Preventive Action (CAPA)

October 27, 2011 | No comments

Corrective and Preventive Action (CAPA) is a component all medical device facilities, whether importer, distributor, or manufacturer, must comply with. …

Read more »
FDAUpdate

Medical Device Pre-Market Programs: An Overview of FDA Actions

October 20, 2011 | No comments

Nearly two years ago, the FDA’s Center for Devices and Radiological Health (CDRH) recognized the need to re-evaluate and modernize …

Read more »
FDAUpdate

Baby Products with SIDS Prevention Claims

October 17, 2011 | No comments

Companies can inadvertenly fall under the FDA’s authority by how they market themselves. Medical devices include any claim to “cure, treat, …

Read more »
CostumeLens

Decorative/Fashion Contact Lenses – Know the Risks

October 12, 2011 | No comments

Advice from the FDA just in time for Halloween. Pseudomonas eye infection. Image courtesy of Thomas Steinemann, MD and MetroHealth …

Read more »

Powered by WordPress. Genius Design by MCS.